Adagio Medical Holdings, Inc. logo

ADGM Earnings Date: Nov 11, 2026 (Estimated) — Adagio Medical Holdings, Inc.

NASDAQ · Healthcare · Medical Devices

Updated

Price $0.09
Market Cap $1.9M
P/E -0.1
52W Range $0.08 – $1.69
Next Earnings · After close (est.)

When is ADGM's next earnings date?

Adagio Medical Holdings, Inc. (ADGM) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.25.

How did ADGM do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Adagio Medical Holdings, Inc. posted EPS of -$0.30 versus the -$0.27 estimate, a miss of 3.5%. Revenue was $0. The stock's 1-day post-earnings move was -3.4%.

How much does ADGM stock move after earnings?

ADGM beat EPS estimates in 1 of its last 3 reported quarters. Over the last 8 reports the stock moved an average of 5.9% (up or down) in the day after earnings.

About Adagio Medical Holdings, Inc.

Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.27-0.30-3.45%$0❌ Miss-3.37%-12.46%-18.70%
2026-05-12Q1 2026-0.30-0.31-3.33%$0❌ Miss-1.83%-6.04%-19.82%
2026-03-27Q4 2025-0.31-0.21+32.26%$0✅ Beat-1.61%+0.81%-7.26%
2025-11-12Q3 2025—-0.66—$0—-3.72%-4.72%+15.79%
2025-08-13Q2 2025—-0.35—$0—-1.17%-3.09%+29.18%
2025-03-31Q4 2024—-3.68—$137,000—-14.36%-21.19%+27.67%
2024-11-14Q3 2024—0.02—$132,000—-19.14%-38.54%-50.67%
2024-08-26Q2 2024—-713794.00—$0—-1.92%-0.96%-33.94%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .